Use Google SSO for the fastest sign-in experience across IP news, saved access limits, and member-only newsroom features. You can still choose another login method if you prefer.
Daily reporting, analysis, and legal-market coverage across patents, trademarks, copyright, licensing, disputes, and policy.
6 articles published on this day, newest first.
Millennium Pharma and its distributor Cilag are not eligible to receive damages from generic companies for the infringement of patents related to ant…
Millennium Pharma and its distributor Cilag are not eligible to receive damages from generic companies for the infringement of patents related to anti-cancer medication Velcade. The Regional Court Düsseldorf dismissed t…
Astronergy and JA Solar ended all global litigation and signed a cross-licensing agreement covering tunnel-oxide passivated contact (TOPCon) solar ce…
Astronergy and JA Solar ended all global litigation and signed a cross-licensing agreement covering tunnel-oxide passivated contact (TOPCon) solar cell patents, resolving a major intellectual-property dispute affecting…
China’s top judicial body has vowed to strengthen the protection of intellectual property rights as part of the efforts to support the country’s goal…
China’s top judicial body has vowed to strengthen the protection of intellectual property rights as part of the efforts to support the country’s goal of achieving a higher level of self-reliance and strengthening the sc…
The global patent disputes between mRNA vaccine manufacturers have once again set the patent community buzzing. While GSK launched several lawsuits a…
The global patent disputes between mRNA vaccine manufacturers have once again set the patent community buzzing. While GSK launched several lawsuits at the UPC against Moderna, BioNTech and Pfizer in July, BioNTech's pen…
Van Loon had applied to inspect and preserve evidence at Inverquark’s exhibition stand in advance of a potential main action, which went ahead despit…
Van Loon had applied to inspect and preserve evidence at Inverquark’s exhibition stand in advance of a potential main action, which went ahead despite a protective letter having been filed previously by the defendant (s…
The SEP licensing and litigation landscape has continued to evolve in the latter half of 2025, shaped by several significant global trends:
The SEP licensing and litigation landscape has continued to evolve in the latter half of 2025, shaped by several significant global trends:
Get Top 5 IP News Today, weekly editorial roundups, and region-aware updates tailored to your practice.
Millennium Pharma and its distributor Cilag are not eligible to receive damages from generic companies for the infringement of patents related to anti-cancer medication Velcade. The Regional Court Düsseldorf dismissed t…
Astronergy and JA Solar ended all global litigation and signed a cross-licensing agreement covering tunnel-oxide passivated contact (TOPCon) solar cell patents, resolving a major intellectual-property dispute affecting…
China’s top judicial body has vowed to strengthen the protection of intellectual property rights as part of the efforts to support the country’s goal of achieving a higher level of self-reliance and strengthening the sc…
The global patent disputes between mRNA vaccine manufacturers have once again set the patent community buzzing. While GSK launched several lawsuits at the UPC against Moderna, BioNTech and Pfizer in July, BioNTech's pen…
Van Loon had applied to inspect and preserve evidence at Inverquark’s exhibition stand in advance of a potential main action, which went ahead despite a protective letter having been filed previously by the defendant (s…
Leading medical technology company Becton Dickinson and Company (BD) has filed a patent infringement lawsuit against Baxter International Inc., claiming that Baxter has unlawfully used BD’s patented technologies in it...
Regularly check our site to learn about PCT filing and more crucial ideas. The patent Cooperation Treaty is known as PCT. It is an international agreement that has more than 150 members. Submitting a single PCT applic...
IIPLA News reviews a fresh appellate development affecting timing strategy and disclaimer analysis in pharmaceutical patent litigation.
Intellectual property (IP) is an essential component of any high-tech start-up's business strategy. However, navigating the complex landscape of IP law can be challenging, and there are many potential pitfalls that st...
Customs and Border Protection (CBP) authorities around the world are stepping up their efforts to combat the growing threat of intellectual property (IP) theft. IP theft, which involves the unauthorized use or copying...